Nov 29 (Reuters) - Pfizer Inc and German partner
BioNTech SE are expected to ask the U.S. Food and
Drug Administration in the next few days to authorize their
COVID-19 vaccine booster shot for 16 and 17-year olds, the
Washington Post reported on Monday, citing two people familiar
with the matter.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by
Krishna Chandra Eluri)